We are on the verge of the Q4 earnings season and it is once again time to review the players in the worldwide medical devices market. For the U.S. medical device industry, spending cuts and ...

On an overcast Tuesday in late March, the LifeLabs workers picketing outside Vancouver’s Regent Medical Building rouse themselves for a cheer.

Today we are looking at Quest (NYSE:DGX) and the best and worst performers in the testing & diagnostics services ... 2025--NeoGenomics announced the acquisition of Pathline, LLC, a CLIA/CAP ...

Readers hoping to buy Quest Diagnostics Incorporated (NYSE:DGX) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend date is one ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Quest Diagnostics has a fifty-two week low of $125.42 and a fifty-two week high of $178.87. The company has a market cap of $18.21 billion, a P/E ratio of 21.34, a PEG ratio of 2.16 and a beta of ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Inicio is a UK-based clinically led healthcare company. LDC portfolio company RDi has completed the acquisition of Inicio Health, a UK-based clinically led healthcare company.

Commentary on tariffs and the consumer will be in the spotlight March core CPI forecast to drop to annual rate of 3% Bill ...